Related Experiment Video
Updated: Nov 11, 2025

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling
Elliott D Bayle1,2, Fredrik Svensson1,2, Benjamin N Atkinson1
1Alzheimer's Research UK UCL Drug Discovery Institute, University College London, Cruciform Building, Gower Street, London WC1E 6BT, U.K.
Abstract:
Regulation of the Wnt signaling pathway is critically important for a number of cellular processes in both development and adult mammalian biology. This Perspective will provide a summary of current and emerging therapeutic opportunities in modulating Wnt signaling, especially through inhibition of Notum carboxylesterase activity. Notum was recently shown to act as a negative regulator of Wnt signaling through the removal of an essential palmitoleate group. Inhibition of Notum activity may represent a new approach to treat disease where aberrant Notum activity has been identified as the underlying cause. Reliable screening technologies are available to identify inhibitors of Notum, and structural studies are accelerating the discovery of new inhibitors. A selection of these hits have been optimized to give fit-for-purpose small molecule inhibitors of Notum. Three noteworthy examples are LP-922056 (26), ABC99 (27), and ARUK3001185 (28), which are complementary chemical tools for exploring the role of Notum in Wnt signaling.
Insights
Inhibiting Notum carboxylesterase activity offers a novel therapeutic strategy for diseases linked to Wnt signaling pathway dysregulation. Small molecule inhibitors are being developed to target Notum, providing new tools for research and treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The Wnt signaling pathway is crucial for mammalian development and adult biology.
- Aberrant Wnt signaling is implicated in various diseases.
- Notum carboxylesterase negatively regulates Wnt signaling by removing a palmitoleate group.
Purpose of the Study:
- To summarize therapeutic opportunities in modulating Wnt signaling.
- To highlight the potential of inhibiting Notum carboxylesterase activity.
- To present small molecule inhibitors of Notum as research tools.
Main Methods:
- Review of current literature on Wnt signaling and Notum.
- Discussion of screening technologies for Notum inhibitors.
- Optimization of identified hits into small molecule inhibitors.
Main Results:
- Notum's role as a negative regulator of Wnt signaling is established.
- Screening and structural studies have accelerated the discovery of Notum inhibitors.
- Several potent small molecule inhibitors, including LP-922056, ABC99, and ARUK3001185, have been developed.
Conclusions:
- Inhibition of Notum activity presents a promising therapeutic avenue for diseases associated with its aberrant function.
- Developed small molecule inhibitors serve as valuable chemical tools for further investigation of Notum's role in Wnt signaling.
- Targeting Notum offers a new strategy for treating diseases driven by Wnt pathway dysregulation.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

